Report Detail

Request for Sample of this report

Service & Software Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2019 by Company, Regions, Type and Application, Forecast to 2024

  • RnM3331396
    • |
  • 19 April, 2019
    • |
  • Global
    • |
  • 135 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Service & Software

Single Nucleotide Polymorphism (SNP) Genotyping is the measurement of genetic variations of single nucleotide polymorphisms (SNPs) between members of a species. It is a form of genotyping, which is the measurement of more general genetic variation. SNP genotyping is not only the genetic markers present in most, but also the most promising markers. SNP genotyping as the most potential for development of molecular markers, it cans achieve large-scale highly automated, thus it is more suited to a huge number of detection and analysis, has been widely used in biology, agriculture, medicine, biological evolution and other fields.

Scope of the Report:
SNP genotyping is the simplest form of DNA variation among individuals. These simple changes can be of transition or transversion type and they occur throughout the genome at a frequency of about one in 1,000 bp. In the whole SNP genotyping industry, only a few companies can provide SNP genotyping platform while SNP genotyping service provider are located widely in the world.

SNP genotyping has various genotyping methods, such as TaqMan probe method, SNaPshot method, .MassArray method, .Illumina BeadXpress, HRM method and so on. Each method has its own characteristics. SNP genotyping will adopt an appropriate method according their customers’ specific demand or wanted results.

Illumina, Affymetrix and Applied Biosystems are industry leaders. They can provide SNP genotyping platform, reagent and service to their clients. Besides, all of them have authorized companies around the word to use their platform to offer genotyping service to some countries. In fact, in the platform field, the industry is still highly monopolized for the time being.

We tend to believe that this industry still has a bright future, considering the current gene research. There is also no doubt that there are will be more and more companies to provide innovative SNP genotyping related products and service to customers in the next few years, promoting the industry to develop healthily.

The global Single Nucleotide Polymorphism (SNP) Genotyping market is valued at 7620 million USD in 2018 and is expected to reach 24100 million USD by the end of 2024, growing at a CAGR of 21.2% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Single Nucleotide Polymorphism (SNP) Genotyping.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Single Nucleotide Polymorphism (SNP) Genotyping market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Single Nucleotide Polymorphism (SNP) Genotyping market by product type and applications/end industries.

Market Segment by Companies, this report covers
Illumina
Affymetrix
Applied Biosystems
Agilent Technologies
Beckman Coulter
Roche
Qiagen
Luminex Corporation
Enzo Life Sciences
Bio-rad
Sequenom
Ocimum Biosolutions
GE Healthcare
GenScript
Douglas Scientific
BGI
Beijing Sunbiotech
HuaGene Biotech
Generay Biotech
Benegene
Shanghai Biochip
GENESKY
HD Biosciences

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Transversion
Transition

Market Segment by Applications, can be divided into
Diagnostics
Animal
Plant
Research
Others


Table of Contents

    1 Single Nucleotide Polymorphism (SNP) Genotyping Market Overview

    • 1.1 Product Overview and Scope of Single Nucleotide Polymorphism (SNP) Genotyping
    • 1.2 Classification of Single Nucleotide Polymorphism (SNP) Genotyping by Types
      • 1.2.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Comparison by Types (2019-2024)
      • 1.2.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Types in 2018
      • 1.2.3 Transversion
      • 1.2.4 Transition
    • 1.3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market by Application
      • 1.3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size and Market Share Comparison by Applications (2014-2024)
      • 1.3.2 Diagnostics
      • 1.3.3 Animal
      • 1.3.4 Plant
      • 1.3.5 Research
      • 1.3.6 Others
    • 1.4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market by Regions
      • 1.4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size (Million USD) Comparison by Regions (2014-2024)
      • 1.4.1 North America (USA, Canada and Mexico) Single Nucleotide Polymorphism (SNP) Genotyping Status and Prospect (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Single Nucleotide Polymorphism (SNP) Genotyping Status and Prospect (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Single Nucleotide Polymorphism (SNP) Genotyping Status and Prospect (2014-2024)
      • 1.4.4 South America (Brazil, Argentina, Colombia) Single Nucleotide Polymorphism (SNP) Genotyping Status and Prospect (2014-2024)
      • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Single Nucleotide Polymorphism (SNP) Genotyping Status and Prospect (2014-2024)
    • 1.5 Global Market Size of Single Nucleotide Polymorphism (SNP) Genotyping (2014-2024)

    2 Manufacturers Profiles

    • 2.1 Illumina
      • 2.1.1 Business Overview
      • 2.1.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Illumina Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Affymetrix
      • 2.2.1 Business Overview
      • 2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Affymetrix Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Applied Biosystems
      • 2.3.1 Business Overview
      • 2.3.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Applied Biosystems Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Agilent Technologies
      • 2.4.1 Business Overview
      • 2.4.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Agilent Technologies Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Beckman Coulter
      • 2.5.1 Business Overview
      • 2.5.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Beckman Coulter Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Roche
      • 2.6.1 Business Overview
      • 2.6.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Roche Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Qiagen
      • 2.7.1 Business Overview
      • 2.7.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Qiagen Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Luminex Corporation
      • 2.8.1 Business Overview
      • 2.8.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Luminex Corporation Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Enzo Life Sciences
      • 2.9.1 Business Overview
      • 2.9.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Enzo Life Sciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Bio-rad
      • 2.10.1 Business Overview
      • 2.10.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Bio-rad Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Sequenom
      • 2.11.1 Business Overview
      • 2.11.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Sequenom Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.12 Ocimum Biosolutions
      • 2.12.1 Business Overview
      • 2.12.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.12.2.1 Product A
        • 2.12.2.2 Product B
      • 2.12.3 Ocimum Biosolutions Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.13 GE Healthcare
      • 2.13.1 Business Overview
      • 2.13.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.13.2.1 Product A
        • 2.13.2.2 Product B
      • 2.13.3 GE Healthcare Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.14 GenScript
      • 2.14.1 Business Overview
      • 2.14.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.14.2.1 Product A
        • 2.14.2.2 Product B
      • 2.14.3 GenScript Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.15 Douglas Scientific
      • 2.15.1 Business Overview
      • 2.15.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.15.2.1 Product A
        • 2.15.2.2 Product B
      • 2.15.3 Douglas Scientific Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.16 BGI
      • 2.16.1 Business Overview
      • 2.16.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.16.2.1 Product A
        • 2.16.2.2 Product B
      • 2.16.3 BGI Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.17 Beijing Sunbiotech
      • 2.17.1 Business Overview
      • 2.17.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.17.2.1 Product A
        • 2.17.2.2 Product B
      • 2.17.3 Beijing Sunbiotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.18 HuaGene Biotech
      • 2.18.1 Business Overview
      • 2.18.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.18.2.1 Product A
        • 2.18.2.2 Product B
      • 2.18.3 HuaGene Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.19 Generay Biotech
      • 2.19.1 Business Overview
      • 2.19.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.19.2.1 Product A
        • 2.19.2.2 Product B
      • 2.19.3 Generay Biotech Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.20 Benegene
      • 2.20.1 Business Overview
      • 2.20.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.20.2.1 Product A
        • 2.20.2.2 Product B
      • 2.20.3 Benegene Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.21 Shanghai Biochip
      • 2.21.1 Business Overview
      • 2.2.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.21.2.1 Product A
        • 2.21.2.2 Product B
      • 2.21.3 Shanghai Biochip Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.22 GENESKY
      • 2.22.1 Business Overview
      • 2.22.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.22.2.1 Product A
        • 2.22.2.2 Product B
      • 2.22.3 GENESKY Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)
    • 2.23 HD Biosciences
      • 2.23.1 Business Overview
      • 2.23.2 Single Nucleotide Polymorphism (SNP) Genotyping Type and Applications
        • 2.23.2.1 Product A
        • 2.23.2.2 Product B
      • 2.23.3 HD Biosciences Single Nucleotide Polymorphism (SNP) Genotyping Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Competition, by Players

    • 3.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Share by Players (2014-2019)
    • 3.2 Market Concentration Rate
      • 3.2.1 Top 5 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share
      • 3.2.2 Top 10 Single Nucleotide Polymorphism (SNP) Genotyping Players Market Share
    • 3.3 Market Competition Trend

    4 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Regions

    • 4.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Market Share by Regions
    • 4.2 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 4.3 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 4.5 South America Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    5 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries

    • 5.1 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries (2014-2019)
    • 5.2 USA Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 5.3 Canada Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 5.4 Mexico Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    6 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries

    • 6.1 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries (2014-2019)
    • 6.2 Germany Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 6.3 UK Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 6.4 France Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 6.5 Russia Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 6.6 Italy Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    7 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries

    • 7.1 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries (2014-2019)
    • 7.2 China Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 7.3 Japan Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 7.4 Korea Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 7.5 India Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    8 South America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries

    • 8.1 South America Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries (2014-2019)
    • 8.2 Brazil Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 8.3 Argentina Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 8.4 Colombia Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    9 Middle East and Africa Revenue Single Nucleotide Polymorphism (SNP) Genotyping by Countries

    • 9.1 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue by Countries (2014-2019)
    • 9.2 Saudi Arabia Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 9.3 UAE Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 9.4 Egypt Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 9.5 Nigeria Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)
    • 9.6 South Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Growth Rate (2014-2019)

    10 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment by Type

    • 10.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue and Market Share by Type (2014-2019)
    • 10.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Type (2019-2024)
    • 10.3 Transversion Revenue Growth Rate (2014-2024)
    • 10.4 Transition Revenue Growth Rate (2014-2024)

    11 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segment by Application

    • 11.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Share by Application (2014-2019)
    • 11.2 Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Application (2019-2024)
    • 11.3 Diagnostics Revenue Growth (2014-2019)
    • 11.4 Animal Revenue Growth (2014-2019)
    • 11.5 Plant Revenue Growth (2014-2019)
    • 11.6 Research Revenue Growth (2014-2019)
    • 11.7 Others Revenue Growth (2014-2019)

    12 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast (2019-2024)

    • 12.1 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size Forecast (2019-2024)
    • 12.2 Global Single Nucleotide Polymorphism (SNP) Genotyping Market Forecast by Regions (2019-2024)
    • 12.3 North America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Forecast (2019-2024)
    • 12.4 Europe Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Forecast (2019-2024)
    • 12.5 Asia-Pacific Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Forecast (2019-2024)
    • 12.6 South America Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Forecast (2019-2024)
    • 12.7 Middle East and Africa Single Nucleotide Polymorphism (SNP) Genotyping Revenue Market Forecast (2019-2024)

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Methodology

      Summary:
      Get latest Market Research Reports on Single Nucleotide Polymorphism (SNP) Genotyping . Industry analysis & Market Report on Single Nucleotide Polymorphism (SNP) Genotyping is a syndicated market report, published as Global Single Nucleotide Polymorphism (SNP) Genotyping Market 2019 by Company, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Single Nucleotide Polymorphism (SNP) Genotyping market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,480.00
      		$5,220.00
      		$6,960.00
      		2,780.52
      		4,170.78
      		5,561.04
      		3,232.92
      		4,849.38
      		6,465.84
      		542,218.80
      		813,328.20
      		1,084,437.60
      		290,719.20
      		436,078.80
      		581,438.40
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo